Sean Saint

with diabetes who'd really been left out in the cold by the pump technologies that existed at that time.

And then years later, to get the opportunity to come sit in this seat was just lightning striking for me.

Yeah, definitely type one.

You know, something we used to call juvenile onset diabetes.

We don't call it that anymore because we've realized that, you know, people can get it in any time.

For me, I was 35.

My wife might argue that I'm still juvenile, but be that as it may, we don't call it that anymore.

Yeah, well, type one, you know, you're on insulin right out of the gate.

No question about that.

Type two diabetes, on the other hand, you definitely do progress, you know, from diet and exercise, et cetera, to oral medications and eventually to basal insulin and maybe intensive insulin therapy where you really are a candidate for something like the islet.

Type two, of course, being a much larger drug.

total population than type one.

But in terms of intensive insulin therapy, type one, type two, about the same size, give or take.

And then there's additional segmentation that we can talk about in terms of who's seeing these patients and the desires of these patients, et cetera.

But it is really designed to increase the penetration of insulin pumps across all those who need them.

Wow, that's a far-reaching question.

Let's start at the beginning and say that people with type 1 diabetes, and certainly type 2 is similar in the way it's treated.

The physiology is a little different, but let's talk about type 1 for a second.

Your body stops producing insulin.

Obviously, it's usually done in the pancreas.